Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Indolepropionic acid - ViroPharma Incorporated

Drug Profile

Indolepropionic acid - ViroPharma Incorporated

Alternative Names: IN-OX1; Indole-3-propionic acid; IPA - ViroPharma Incorporated; OX-1; Oxigon; SHP 22; SHP-622; VP-20629

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator New York University; University of South Alabama
  • Developer Intellect Neurosciences; ViroPharma Incorporated
  • Class Antidementias; Indoles; Neuroprotectants; Propionic acids; Small molecules
  • Mechanism of Action Amyloid inhibitors; Antioxidants; Chelating agents; Free radical scavengers; Protein aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Alzheimer's disease; Friedreich's ataxia

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Friedreich's ataxia in USA (PO, Capsule)
  • 01 Jul 2015 Shire ViroPharma completes a phase I trial in Friedreich's ataxia in USA (NCT01898884)
  • 11 Mar 2014 ViroPharma is now called Shire ViroPharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top